Early detection of an endometrial cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Slides:

Advertisements

Similar presentations

Hong CM, Ahn BC, Jeong SY, Lee SW, Lee J

Advertisements

The Thyroid Incidentaloma

FDG-PET in Aggressive Lymphoma Chen Shih-Wei, SKH.

Clinical Significance of Preoperative 18F-FDG PET Non- Avidity in Papillary Thyroid Carcinoma Do Hoon Koo 1, Ho-Young Lee 2, Kyu Eun Lee 3,4, So Won Oh.

18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis

ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS. DR.VAISHNAVATHI.V.V. DR.ANUPAMA CHANDRASEKHARAN.

 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 

Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.

A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.

Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.

Case Report # 1 Submitted By: Samuel Oats, MSIV Radiological Category: Body Principal Modality (1): Principal Modality (2): PET/CT CT Faculty Reviewer:

© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.

Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.

MedPix Medical Image Database COW - Case of the Week Case Contributor: Hugh M Dainer Affiliation: National Capital Consortium.

Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.

Dual-time point 18F-FDG PET/CT scan: is it always working?

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Endometrial Carcinoma

Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.

18 FDG PET/CT in the diagnosis of Malignant Peripheral Nerve Sheath Tumours VS Warbey, RE Ferner, JT Dunn, E Calonje, MJ O’Doherty St Thomas’ Clinical.

ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/2/09.

Follow up in Chest Tumors : Value of integrated PET/CT By : Dr. Heba Nabil, MSc Radiology Specialist at Nasser Institute For Research and Treatment.

核子醫學科陳明宗醫師財團法人新光吳火獅紀念醫院 Bizarre Location of colorectal Cancer.

11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,

Early detection of a colon cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Targeting HER2 and Focusing on Patients With Gastric Cancer Jose Maria Vieitez, MD, PhD Assistant Professor of Oncology Department of Medical Oncology.

Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,

Unexpected additional lung cancer in a patient with already known inflammatory myofibroblastic tumor detected on PET/CT Kaohsiung Veterans General Hospital.

By: Maureen Jaminal BIOL 316

TEMPLATE DESIGN © Endometrial large cell neuroendocrine carcinoma ： a case report Reina Sato, Aiko Kawano, Hiroyuki Shigeta.

ACRIN 6682 Phase II Trial of 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 9/30/10.

Monitoring the radioimmunotherapeutic effect by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

NYU Medicine Grand Rounds Clinical Vignette David Altszuler, MD PGY-2 December 11, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

FDG PET/CT case report early detection of ovarian cancer NM case conference, chairman: Nan-Jing Peng, MD.

Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,

Verluma Nofetumomab Merpentan (Fragment). Indications For the detection and staging of previously untreated small cell lung cancer. It must be confirmed.

Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.

Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.

ACRIN 6682 Phase II Trial OF 64 Cu-ATSM PET/CT in Cervical Cancer Principal Investigator: Farrokh Dehdashti, MD 10/4/08.

Albert J. Chang, MD, PhD 1 Farrokh Dehdashti, MD 2 Perry W. Grigsby, MD, MS 1 Department of Radiation Oncology 1 Department of Radiology and Nuclear Medicine.

Unexpected additional thyroid cancer in a patient with already known cervical cancer detected on PET/CT Kaohsiung Veterans General Hospital Kuan-Hsiu Lin,

Diagnostic Challenge Pathology for Neurosurgery & Neurology Residents Department of Pathology University of Oklahoma Health Sciences Center, Oklahoma City,

PET/MR in Oncology: Non– 18 F- FDG Tracers for Routine Applications R2 丁建鑫.

부산대학교병원 김 주 연 2012 년 세포병리학회 가을학술대회 월례집담회.  F/52  Past history : 03’ left breast operation, on follow up  Lower abdominal pain (12’ April)  Physical.

Authors: Syed H. Jafri ¹, Angel I. Blanco¹, Bonnie A. Labdi², Shan Guo¹. UT Houston department of medicine, Division of Oncology Department of Pharmacy.

간담도 암에서의 PET 의 활용 핵의학과 홍일기. 18 F-FDG PET: Warburg effect.

Cytopathology Feb

Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.

CHONBUK NATIONAL UNIVERSITY HOSPITAL Great Day to you! CHON BUK NATIO NAL UNIVE RSITY HOSPI TAL GIM BYUNG CHUL The Change on PET/CT Image of Patients with.

M.D. Browning, M.D. ‘77.  Most Common Cancer of Female Reproductive System  60,000/year with 10,000 deaths  Normal Cells in the Endometrium.

Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A

TMIST A Breast Cancer Screening Trial

PET Applications in Oncology 2015/2016

CT and PET imaging in non-small cell lung cancer

PET Criteria for Response Assessment After Completion of Therapy for Aggressive NHL and HL Definition of a positive PET scan (Visual assessment is adequate,

Prostate Cancer Dr .Gehan Mohamed.

Keith E. Kelly, MD and William H. Culbertson, MD

Sentinel lymph node and lymphatic mapping using indocyanine green for endometrium cancer: a case report. Suat Karatas, Veysel Sal, Emel Canaz, Meltem.

Radio Iodine Therapy In Cancer Thyroid

Uterine cancer Uterine mesenchymal neoplasms

The most common origin of cervical squamous cell carcinoma

Nofetumomab Merpentan (Fragment)

Focus on endometrial and cervical cancer

European Urology Oncology

The role of positron emission tomography for non-small cell lung cancer Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD Practical.

Metabolic PHENOTYPE by NMR spectroscopy: A biomarker for lung CANCER

A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib Oliver Gautschi, MD, Chantal Pauli, MD, Klaus Strobel, MD, Astrid Hirschmann,

Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report Giacomo Corrado, M.D., Ph.D., Ermelinda.

Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT Maria Victoria Orcurto, MD, Angelika.

Presentation transcript:

Early detection of an endometrial cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine

Abstract: Whole-body FDG-PET has been used to screen underlying malignancy of health people for decades. Recently, PET/CT has been advocated as a tool for improvement of diagnosis by FDG-PET. We assessed the PET/CT results of asymptomatic individuals for health screening in our PET center. The final confirmation of cancer was based on pathologic report. Here, a case of endometrial cancer was presented.

PET/CT There are several abnormal FDG-avid areas including : 1. two hot spots in the thyroid gland (SUV max early: 5.8, delayed: 10.5 on the left, and SUV max early: 4.0, delayed: 4.3 on the right). 2. diffuse high FDG uptake in the central portion of uterus (SUV max & mean: early: 10.3 & 9.2, delayed: 16 & 12.8). Ancillary tumor markers and thyroid hormone tests were also performed, which showed all within normal limits. Tracing her history, endometrial hyperplasia is noted for one and half a years. Impression: 1. Certain lesions in the thyroid gland, especially the left one. Malignant tumor can’t be ruled out. 2. Compatible with endometrial hyperplasia. Malignancy can’t be completely ruled out. Pathological diagnosis: #08 Uterus, labelled "endocervix", D&C ----- Adenocarcinoma, endometroid type, FIGO grade 1 #01 Uterus, endometrium, ATH+BSO+BPLND+para-aortic LN sampling----Adenocarcinoma, endometrioid type, moderately differentiated without lymph nodal metastasis